The effect of potassium citrate and double j stent in reducing stone formation

Evaluation of the combined effect of potassium citrate consumption and the comparison of double j stent in reducing the formation of urinary tract stones

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190624043991N8

Enrollment

Registered

2020-08-11

Start date

2020-06-28

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary stones. Calculus of kidney with calculus of ureter

Interventions

Intervention 1: Intervention group: Patients receiving Double j with placebo. Intervention 2: Intervention group: Patients receiving double j in addition to potassium citrate.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing tulle (Trans Ureteral Lithotripsy). Patients undergoing pcnl (Percutaneous nephrolithotomy). Patients with Double j.

Exclusion criteria

Exclusion criteria: Having diabetes with poor blood control Digoxin for heart problems Concomitant use of calcium supplements Taking potassium-sparing diuretics Previous history of hypercalcemia use of Levodopa Blood sugar above 160 mg two hours after a meal despite taking diabetes medications Take any amount of spironolactone, triamterene and amiloride tablets High blood potassium more than 5 GFR less than 70 Pregnancy

Design outcomes

Primary

Measure	Time frame
Re-formation of stone on Dj stent due to the presence of citrate and the absence of citrate. Timepoint: Immediately after leaving Dj stent. Method of measurement: Pathology and Stone Detection Laboratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Akram Mirzaei

Tehran University of Medical Sciences

mirzaee.scholar@gmail.com+98 21 6634 8560

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026